APA (7th ed.) Citation

YL, Q., T, W., RC, L., YM, H., LH, W., CG, L., . . . NS, X. (2020). Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial. Journal of the National Cancer Institute, 112(2), 145. https://doi.org/10.1093/jnci/djz074

Chicago Style (17th ed.) Citation

YL, Qiao, et al. "Efficacy, Safety, and Immunogenicity of an Escherichia Coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial." Journal of the National Cancer Institute 112, no. 2 (2020): 145. https://doi.org/10.1093/jnci/djz074.

MLA (9th ed.) Citation

YL, Qiao, et al. "Efficacy, Safety, and Immunogenicity of an Escherichia Coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial." Journal of the National Cancer Institute, vol. 112, no. 2, 2020, p. 145, https://doi.org/10.1093/jnci/djz074.